HealthHackadayabout 1 hour ago
Study Tests CRISPR Cancer Therapy in Mice
5 min read
A June 2026 study by Jingkun Zeng et al. in Nature tests a CRISPR-Cas12a2 therapy targeting the TP53 gene in mice with lung tumors. While the treatment suppressed tumor growth, it failed to cure advanced tumors, suggesting the approach remains a step forward rather than an immediate cure for cancer patients.
Level
Hype check
Tap to vote and see what everyone thinks.
